Study in Adult and Adolescent Subjects With PAR (Perennial Allergic Rhinitis)

NCT01134705 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

474

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinitis, Allergic, Perennial

Interventions

DRUG: Beclomethasone dipropionate hydrofluoroalkane HFA Nasal Aerosol
DRUG: Placebo Nasal Aerosol

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.